Literature DB >> 25075535

Diabetes and cognitive outcomes in a nationally representative sample: the National Health and Aging Trends Study.

Alexandra M V Wennberg1, Rebecca F Gottesman2, Christopher N Kaufmann1, Marilyn S Albert2, Lenis P Chen-Edinboro1, George W Rebok1, Judith D Kasper3, Adam P Spira1.   

Abstract

BACKGROUND: The prevalence of both type II diabetes mellitus (DM) and cognitive impairment is high and increasing in older adults. We examined the extent to which DM diagnosis was associated with poorer cognitive performance and dementia diagnosis in a population-based cohort of US older adults.
METHODS: We studied 7,606 participants in the National Health and Aging Trends Study, a nationally representative cohort of Medicare beneficiaries aged 65 years and older. DM and dementia diagnosis were based on self-report from participants or proxy respondents, and participants completed a word-list memory test, the Clock Drawing Test, and gave a subjective assessment of their own memory.
RESULTS: In unadjusted analyses, self-reported DM diagnosis was associated with poorer immediate and delayed word recall, worse performance on the Clock Drawing Test, and poorer self-rated memory. After adjusting for demographic characteristics, body mass index, depression and anxiety symptoms, and medical conditions, DM was associated with poorer immediate and delayed word recall and poorer self-rated memory, but not with the Clock Drawing Test performance or self-reported dementia diagnosis. After excluding participants with a history of stroke, DM diagnosis was associated with poorer immediate and delayed word recall and the Clock Drawing Test performance, and poorer self-rated memory, but not with self-reported dementia diagnosis.
CONCLUSIONS: In this recent representative sample of older Medicare enrollees, self-reported DM was associated with poorer cognitive test performance. Findings provide further support for DM as a potential risk factor for poor cognitive outcomes. Studies are needed that investigate whether DM treatment prevents cognitive decline.

Entities:  

Mesh:

Year:  2014        PMID: 25075535      PMCID: PMC4199187          DOI: 10.1017/S1041610214001380

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  26 in total

1.  IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030.

Authors:  David R Whiting; Leonor Guariguata; Clara Weil; Jonathan Shaw
Journal:  Diabetes Res Clin Pract       Date:  2011-11-12       Impact factor: 5.602

2.  Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy.

Authors:  Lenore J Launer; Michael E Miller; Jeff D Williamson; Ron M Lazar; Hertzel C Gerstein; Anne M Murray; Mark Sullivan; Karen R Horowitz; Jingzhong Ding; Santica Marcovina; Laura C Lovato; James Lovato; Karen L Margolis; Patrick O'Connor; Edward W Lipkin; Joy Hirsch; Laura Coker; Joseph Maldjian; Jeffrey L Sunshine; Charles Truwit; Christos Davatzikos; R Nick Bryan
Journal:  Lancet Neurol       Date:  2011-09-28       Impact factor: 44.182

3.  Association of duration and severity of diabetes mellitus with mild cognitive impairment.

Authors:  Rosebud O Roberts; Yonas E Geda; David S Knopman; Teresa J H Christianson; V Shane Pankratz; Bradley F Boeve; Adrian Vella; Walter A Rocca; Ronald C Petersen
Journal:  Arch Neurol       Date:  2008-08

Review 4.  Insulin, cognition, and dementia.

Authors:  Brenna Cholerton; Laura D Baker; Suzanne Craft
Journal:  Eur J Pharmacol       Date:  2013-09-23       Impact factor: 4.432

5.  Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study.

Authors:  E M C Schrijvers; J C M Witteman; E J G Sijbrands; A Hofman; P J Koudstaal; M M B Breteler
Journal:  Neurology       Date:  2010-11-30       Impact factor: 9.910

Review 6.  Cognitive dysfunction in patients with type 2 diabetes.

Authors:  Yael D Reijmer; Esther van den Berg; Carla Ruis; L Jaap Kappelle; Geert Jan Biessels
Journal:  Diabetes Metab Res Rev       Date:  2010-10       Impact factor: 4.876

Review 7.  Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review.

Authors:  Raoul P Kloppenborg; Esther van den Berg; L Jaap Kappelle; Geert Jan Biessels
Journal:  Eur J Pharmacol       Date:  2008-03-04       Impact factor: 4.432

Review 8.  Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis.

Authors:  Feng-Ping Lu; Kun-Pei Lin; Hsu-Ko Kuo
Journal:  PLoS One       Date:  2009-01-07       Impact factor: 3.240

9.  Economic costs of diabetes in the U.S. in 2012.

Authors: 
Journal:  Diabetes Care       Date:  2013-03-06       Impact factor: 19.112

10.  Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study.

Authors:  Weili Xu; Chengxuan Qiu; Margaret Gatz; Nancy L Pedersen; Boo Johansson; Laura Fratiglioni
Journal:  Diabetes       Date:  2008-10-24       Impact factor: 9.461

View more
  6 in total

1.  Napping characteristics and cognitive performance in older adults.

Authors:  Jocelynn T Owusu; Alexandra M V Wennberg; Calliope B Holingue; Marian Tzuang; Kylie D Abeson; Adam P Spira
Journal:  Int J Geriatr Psychiatry       Date:  2018-10-12       Impact factor: 3.485

2.  Longitudinal association between diabetes and cognitive decline: The National Health and Aging Trends Study.

Authors:  Alexandra M V Wennberg; Clinton E Hagen; Rebecca F Gottesman; Vadim Zipunnikov; Christopher N Kaufmann; Marilyn S Albert; George W Rebok; Judith D Kasper; Adam P Spira
Journal:  Arch Gerontol Geriatr       Date:  2017-05-16       Impact factor: 3.250

3.  Intrinsic functional connectivity alterations of the primary visual cortex in patients with proliferative diabetic retinopathy: a seed-based resting-state fMRI study.

Authors:  Yao Yu; Dong-Yi Lan; Li-Ying Tang; Ting Su; Biao Li; Nan Jiang; Rong-Bin Liang; Qian-Min Ge; Qiu-Yu Li; Yi Shao
Journal:  Ther Adv Endocrinol Metab       Date:  2020-10-19       Impact factor: 3.565

4.  High glucose induces formation of tau hyperphosphorylation via Cav-1-mTOR pathway: A potential molecular mechanism for diabetes-induced cognitive dysfunction.

Authors:  Jing Wu; Shan-Lei Zhou; Lin-Hua Pi; Xia-Jie Shi; Ling-Ran Ma; Zi Chen; Min-Li Qu; Xin Li; Sheng-Dan Nie; Duan-Fang Liao; Jin-Jing Pei; Shan Wang
Journal:  Oncotarget       Date:  2017-06-20

5.  Cognitive impairment and dependence of patients with diabetes older than 65 years old in an urban area (DERIVA study).

Authors:  Emiliano Rodríguez-Sánchez; Sara Mora-Simón; María C Patino-Alonso; Diana Pérez-Arechaederra; José I Recio-Rodríguez; Manuel A Gómez-Marcos; Luis F Valero-Juan; Luis García-Ortiz
Journal:  BMC Geriatr       Date:  2016-02-01       Impact factor: 3.921

Review 6.  Role of Caveolin-1 in Diabetes and Its Complications.

Authors:  Dania Haddad; Ashraf Al Madhoun; Rasheeba Nizam; Fahd Al-Mulla
Journal:  Oxid Med Cell Longev       Date:  2020-01-27       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.